News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Envoy Therapeutics to Seek New Parkinson's Disease Therapy with The Scripps Research Institute



7/27/2010 8:08:57 AM

JUPITER, Fla.--(BUSINESS WIRE)--Envoy Therapeutics Inc., a recently formed drug discovery company, today announced that it has begun a research collaboration with The Scripps Research Institute to identify new drugs for Parkinson’s disease (PD) that have greater efficacy and safety compared to current therapies. Using funding provided by Envoy, scientists at the two organizations will apply Scripps - Florida’s high-throughput screening capabilities to discover compounds that modulate a target protein discovered by Envoy.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES